Array Biopharma (ARRY) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $8.54 --0%
Revenue Growth %: -11.6%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -11.6%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q4 EPS of ($0.09), $0.07 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $12.3 million versus the consensus estimate of $10.29 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'
- Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
